Positive response to intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to punctate inner choroidopathy

Retina

Volumn 30, Issue 9, 2010, Pages 1400-1404

  Menezo, Victor ^a   Cuthbertson, Fiona ^a   Downes, Susan M ^a  

^a OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

anti VEGF agents,inflammation; antivascular endothelial growth factor; choroidal neovascularization; punctate inner choroidopathy

Indexed keywords

BEVACIZUMAB; PREDNISOLONE; RANIBIZUMAB; TRIAMCINOLONE; VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CHOROID DISEASE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; PHOTODYNAMIC THERAPY; PUNCTATE INNER CHOROIDOPATHY; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISION;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROID DISEASES; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 78049247941     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181d374dc     Document Type: Article

References (25)

1. Watzke RC, Packer AJ, Folk JC, Benson WE, Burgess D, Ober RR. Punctate inner choroidopathy. Am J Ophthalmol 1984;98:572-584.
2. Gerstenblith AT, Thome JE, Sobrin L, et al. Punctate inner choroidopathy: A survey analysis of 77 persons. Ophthalmol ogy 2007;114:1201-1204. (Pubitemid 46829383)
3. Brueggeman RM, Noffke AS, Jampol LM. Resolution of punctate inner choroidopathy lesions with oral prednisone therapy. Arch Ophthalmol 2002;120:996.
4. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroid-opathy, or of idiopathic origin. Am J Ophthal mol 2007;143: 977-983.
5. Coco RM, de Souza CF, Sanabria MR. Photodynamic ther apy for subfoveal and juxtafoveal choroidal neovasculariza tion associated with punctate inner choroidopathy. Ocul Im munol Inflamm 2007;15:27-29.
6. Fong KC, Thomas D, Amin K, Inzerillo D, Horgan SE. Photodynamic therapy combined with systemic corticosteroids for choroidal neovascularisation secondary to punctate inner choroidopathy. Eye 2008;22:528-533. (Pubitemid 351565615)
7. Olsen TW, Capone A Jr, Sternberg P Jr, Grossniklaus HE, Martin DF, Aaberg TM Sr. Subfoveal choroidal neovascula-rization in punctate inner choroidopathy. Surgical management and pathologic findings. Ophthalmology 1996;103:2061-2069.
8. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ. Intravitreal bevacizumab (Avastin) for neo vascular age-related macular degeneration. Ophthalmology 2006;113:363-372.e5.
9. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431. (Pubitemid 44511557)
10. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-390. (Pubitemid 44197628)
11. Ishibashi T, Hata Y, Yoshikawa H, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 1997;235:159-167. (Pubitemid 27129479)
12. Kwak N, Okamoto N, Wood JM, Campochiaro PA. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 2000;41:3158-3164.
13. Sakaguchi H, Ikuno Y, Gomi F, et al. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 2007;91:161-165. (Pubitemid 46202863)
14. Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS. Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myo pia. Br J Ophthalmol 2007;91:157-160. (Pubitemid 46202862)
15. Bhatnagar P, Freund KB, Spaide RF, et al. Intravitreal bev acizumab for the management of choroidal neovasculariza tion in pseudoxanthoma elasticum. Retina 2007;27:897-902. (Pubitemid 47479384)
16. Derriman L, Marshall J, Moorman C, Downes SM. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs). Retina 2008;28:910; author reply 910-911.
17. Fine HF, Zhitomirsky I, Freund KB, et al. Bevacizumab (Avastin) and ranibizumab (Lucentis) for choroidal neovas cularization in multifocal choroiditis. Retina 2009;29:8-12.
18. Mansour AM, Mackensen F, Arevalo JF, et al. Intravitreal bevacizumab in inflammatory ocular neovascularization. Am J Ophthalmol 2008;146:410-416.
19. Photodynamic therapy of subfoveal choroidal neovascular ization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials-TAP report. Treatment of Age-related macular degeneration with Photo dynamic therapy (TAP) Study Group. Arch Ophthalmol 1999; 117:1329-1345.
20. Penfold PL, Wen L, Madigan MC, King NJ, Provis JM. Modulation of permeability and adhesion molecule expres sion by human choroidal endothelial cells. Invest Ophthalmol VisSci 2002;43:3125-3130. (Pubitemid 34977068)
21. Flaxel CJ, Owens SL, Mulholland B, Schwartz SD, Gregor ZJ. The use of corticosteroids for choroidal neovascularisa tion in young patients. Eye 1998;12:266-272. (Pubitemid 28263868)
22. Brown J Jr, Folk JC, Reddy CV, Kimura AE. Visual prog nosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996; 103:1100-1105.
23. Lim JI, Flaxel CJ, LaBree L. Photodynamic therapy for choroi-dal neovascularisation secondary to inflammatory chorioretinal disease. Ann Acad Med Singapore 2006;35:198-202. (Pubitemid 43909705)
24. Leslie T, Lois N, Christopoulou D, et al. Photodynamic therapy for inflammatory choroidal neovascularisation unre sponsive to immunosuppression. Br J Ophthalmol 2005;89: 147-150. (Pubitemid 40175208)
25. Postelmans L, Pasteels B, Coquelet P, Olson JA, Forrester JV. Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neo vascularization in young females. Am J Ophthalmol 2004;138: 803-808 (Pubitemid 39452928)